Dr. Miver Erem Tokuş
NeurosurgeryVerified
- 24+years exp.
English · Turkish
60 seconds · no obligationView Profile
What a craniotomy involves, how neurosurgeons temporarily remove a bone flap to access the brain, indications including tumour resection and vascular malformations, approximate costs in Turkey compared with the UK, US and Germany, what to expect during hospitalisation and rehabilitation, surgical risks and questions to ask your multidisciplinary surgical team.
A written plan with the surgeon's name and the full price — usually within 24 hours.

1 doctor Compare doctors, ratings and prices — ask any of them for a free quote.
NeurosurgeryVerified
English · Turkish
60 seconds · no obligationView Profile
A craniotomy is a specialised neurosurgical operation in which a section of the skull bone, known as a bone flap, is temporarily removed to provide the surgical team with direct access to the brain tissue beneath. Once the intracranial procedure is completed—such as removing a tumour, repairing a vascular defect, or relieving acute pressure—the surgeon secures the bone flap back into its original position using miniature titanium plates and screws. Depending on the condition being treated and the tumour location, hospitals in Turkey perform this procedure under general anaesthesia or, when mapping speech and motor pathways, as an awake craniotomy.
A craniotomy in Turkey is performed for several critical neurosurgical conditions. Common indications include resecting benign or malignant brain tumours (such as meningiomas, gliomas, and metastases), clipping cerebral aneurysms, excising arteriovenous malformations, draining intracranial haematomas following trauma, and treating Chiari malformations. Because cranial surgery demands advanced hospital infrastructure, surgical microscopes, and high-precision neuronavigation technology, many international patients travel to specialized neurosurgical centres; see our guide to neurosurgery treatments in Turkey.
The surgical journey begins with comprehensive diagnostic imaging, including high-resolution contrast magnetic resonance imaging (MRI) and computed tomography (CT) scans. In modern operating theatres, these digital scans are integrated into computerised neuronavigation platforms. These systems function like a surgical satellite navigation system, projecting three-dimensional coordinates of the lesion in real time. The patient's head is stabilised securely in a dedicated cranial fixation frame to prevent any microscopic movement during surgery.
Following the induction of anaesthesia, the neurosurgeon marks a curved incision along the scalp, designed where possible behind the natural hairline to conceal scars. Using a high-speed neurosurgical drill and an automated craniotome with a protective footplate that shields the dura mater, several small burr holes are created and connected to release the bone flap. The dura mater—the protective fibrous membrane covering the brain—is carefully incised and folded back under high-magnification operating microscopes.
Working with micro-instruments, ultrasonic surgical aspirators, and intraoperative neurophysiological monitoring, the surgical team navigates through natural brain fissures to access the pathology. When tumours sit within or adjacent to eloquent speech or movement centres, an awake craniotomy protocol allows speech therapists and neurophysiologists to interact with the patient continuously during cortical mapping. Once the surgical objective is met and meticulous haemostasis is confirmed, the dura is sutured watertight, the bone flap is refixed securely with titanium mini-plates, and the scalp is closed in layers.
Extensive clinical data documented by respected surgical registries and organisations such as the European Association of Neurosurgical Societies and the Society of British Neurological Surgeons confirm that open craniotomy remains the benchmark procedure for substantial intracranial lesions. Surgical efficacy is evaluated against clear clinical endpoints: achieving maximal safe resection of tumours, relieving intracranial hypertension, securing aneurysms against catastrophic rupture, and obtaining definitive tissue for histological and molecular profiling.
Clinical evidence demonstrates that maximal safe debulking of brain tumours significantly improves neurological outcomes, reduces seizure frequency, and enhances responsiveness to subsequent oncological treatments. However, surgery has distinct biological boundaries. For infiltrative high-grade tumours, microscopic tumour cells extend beyond visible margins on MRI; surgery debulks the primary mass, but adjuvant chemotherapy and radiotherapy remain essential. For vascular lesions, successful surgical clipping provides durable protection against haemorrhage. Honest surgical teams clarify that while craniotomy achieves structural decompression and excision, functional recovery depends on underlying pathology, baseline neurological health, and structured neuro-rehabilitation.
The craniotomy price varies across international destinations based on healthcare operational costs, hospital stay length, and required surgical technologies. The ranges below reflect estimated package prices for elective neurosurgical procedures, rather than hospital-specific quotes. Each patient receives an individualized calculation based on their specific imaging review.
| Country | Approximate cost range |
|---|---|
| Turkey | €8,000 – €22,000 |
| United Kingdom | €22,000 – €55,000 |
| United States | €45,000 – €140,000 |
| Germany | €18,000 – €48,000 |
Several clinical variables affect the final craniotomy cost. Complex skull base resections, vascular malformations, and procedures requiring functional brain mapping or extensive intraoperative neuro-monitoring require longer surgical times and larger clinical teams. In Turkey, comprehensive neurosurgery packages typically include pre-operative imaging and laboratory tests, surgical fees, anaesthesia, one to two nights in an intensive care unit, four to six nights in an inpatient room, essential medications, nursing care, and airport-to-hospital transfers. Always confirm whether emergency contingencies, blood transfusions, and prolonged intensive care stays are covered in writing.
Not every intracranial condition requires an open craniotomy. Depending on the exact anatomical location, size, and vascularity of the lesion, neurosurgeons evaluate alternative access techniques. For pituitary adenomas and midline skull base lesions, surgeons frequently enter through the nasal cavity; see our detailed guide to transnasal resection of tumor. Alternatively, small, deep, or surgically inaccessible lesions may be treated without incisions using stereotactic radiosurgery platforms such as Gamma Knife or CyberKnife.
| Approach | Best suited to | Typical limits |
|---|---|---|
| Open craniotomy | Large tumours, vascular malformations, convexity lesions, acute decompression | Involves bone flap removal, longer hospital stay, surgical recovery time |
| Minimally invasive keyhole craniotomy | Selected superficial or small deep lesions accessed through mini-openings | Narrower surgical field; limited illumination and manoeuvre space |
| Transnasal endoscopic surgery | Pituitary adenomas, craniopharyngiomas, central skull base tumours | Restricted to midline skull base; risk of post-op CSF leak through nose |
| Stereotactic radiosurgery | Small brain metastases, vestibular schwannomas, small residual lesions | Does not provide tissue histology; delayed effect over several months |
Choosing the appropriate surgical approach requires thorough evaluation by an experienced multidisciplinary team. A dedicated neurosurgical committee will review your contrast MRI and CT scans to determine whether an open craniotomy is required for definitive removal or whether an alternative approach is suitable; explore related neurosurgery treatments in Turkey.
A craniotomy is recommended for patients diagnosed with intracranial lesions that produce mass effect, progressive neurological symptoms, uncontrolled seizures, or life-threatening vascular risks that cannot be addressed conservatively. Favourable surgical candidates possess adequate general medical health, manageable cardiovascular and pulmonary function, and well-circumscribed lesions where surgical excision provides a distinct therapeutic advantage or vital tissue diagnosis.
Conversely, patients may not be suitable candidates if they present with unmanaged severe systemic illnesses, profound bleeding disorders, or advanced multi-organ impairment that creates unacceptable anaesthetic risk. Furthermore, lesions located deep within the brainstem or diffuse, bilateral infiltrative processes where surgical resection would result in severe functional impairment are rarely managed with open surgery. In such cases, non-invasive radiotherapy, systemic medical therapies, or stereotactic needle biopsy may be recommended instead.
Understanding craniotomy before and after outcomes requires focusing on clinical and radiological recovery rather than cosmetic changes. In neurosurgery, success is defined by post-operative imaging verifying tumour clearance, relief of raised intracranial pressure, and preservation of neurological capabilities. An early contrast MRI scan performed within 24 to 72 hours following surgery confirms the extent of resection and monitors post-operative healing.
In the initial weeks following surgery, patients often experience temporary fatigue, mild headaches, local scalp tenderness, and occasional transient neurological fluctuation due to localized brain swelling. Complete brain tissue healing and functional stabilization progress over three to six months. Many individuals benefit from coordinated neuro-rehabilitation, including physiotherapy, speech therapy, and occupational therapy, to regain strength, balance, and fine motor coordination.
Organizing a craniotomy Turkey journey involves careful planning for both the hospital stay and outpatient recovery. Patients travelling abroad should plan a total stay of 14 to 21 days. The inpatient phase typically spans five to eight days, including one to two nights in a specialized neuro-intensive care unit for continuous physiological monitoring. Scalp sutures or surgical staples are usually removed between days 10 and 14 during a detailed outpatient assessment.
The primary consideration governing the craniotomy recovery timeline and travel safety is the risk of pneumocephalus—small amounts of intracranial air introduced during surgery. Under commercial aircraft cabin pressure changes, trapped air can expand and cause dangerous tension pneumocephalus. Consequently, neurosurgeons perform a pre-flight CT scan to verify that intracranial air has fully absorbed before issuing a fit-to-fly certificate. At home, patients should rest quietly, avoiding strenuous exercise, heavy lifting, and driving for at least six to eight weeks.
Like any major surgical intervention involving the nervous system, a craniotomy carries known medical and neurological risks that must be considered alongside the consequences of omitting treatment. Respected health authorities, including the National Health Service and international neurosurgical associations, emphasize that safety is maximized when operations take place in accredited tertiary hospitals equipped with specialized intensive care units.
General surgical risks include wound infection, deep vein thrombosis, pulmonary embolism, and adverse reactions to general anaesthesia. Specific neurosurgical complications include post-operative intracranial haematoma, brain oedema, cerebrospinal fluid leak from the dural repair, post-operative seizures, meningitis, and new or aggravated neurological deficits affecting speech, strength, sensation, or vision. Surgical teams minimize these risks through pre-operative 3D trajectory planning, continuous intraoperative neuro-monitoring, strict microvascular haemostasis, prophylactic antibiotics, and anti-seizure medications.
When selecting a hospital for cranial surgery abroad, verify that the facility holds international accreditation (such as JCI or ISO), features an on-site 24/7 neuro-intensive care unit, and houses modern neuro-navigation and operating microscopes. Ensure the attending neurosurgeon has documented specialist training and substantial experience in cranial surgery. Read how it works to review the international patient journey, from initial scan assessment to discharge.
Be vigilant regarding common medical red flags. Avoid clinics that offer fixed price quotes without examining your recent MRI or CT scans, promise certain cure rates or complete freedom from complications, operate in facilities without intensive care backup, or exert pressure to secure deposits quickly. A reputable medical centre will always provide a transparent clinical evaluation; request an objective, itemized plan through our free quote page.
Preparing specific questions helps you evaluate your surgical team and ensure you have all essential details before travelling:
A craniotomy is a neurosurgical operation where a section of the skull bone, called a bone flap, is temporarily removed to access the brain. It allows neurosurgeons to treat brain tumours, aneurysm malformations, haematomas, or intracranial pressure before replacing and securing the bone flap with titanium plates.
Yes, a craniotomy is the clinical standard for directly accessing and removing intracranial tumours. It enables gross total resection, relieves mass effect, and provides essential tissue samples for histopathology. While surgery removes visible tumour mass, malignant conditions often require subsequent radiotherapy and chemotherapy to eliminate microscopic cells.
The approximate cost for a planned craniotomy in Turkey typically ranges from €8,000 to €22,000, compared with €22,000 to €55,000 in the UK. The price depends on tumour location, surgical duration, required intraoperative neuro-monitoring, and time spent in the neuro-intensive care unit. Hospitals provide itemised quotes following scan review.
Before surgery, patients undergo contrast MRI, CT mapping, and anaesthetic evaluations. Afterwards, expect temporary swelling, fatigue, and headache while recovering in the hospital. Post-operative imaging verifies tumour resection, and gradual improvements in symptoms and functional mobility occur over several weeks to months, often supported by targeted physical and speech rehabilitation.
Hospital recovery lasts around five to eight days, including one to two nights in intensive care. Most patients resume light walking within days of surgery, but returning to work, driving, and normal daily routines typically requires six to twelve weeks. Complete neurological and bone healing continues over several months.
The brain itself does not feel pain. Surgery is performed under general or monitored local anaesthesia. Post-operatively, patients commonly experience moderate wound soreness, tension headaches, and neck stiffness from muscle manipulation. These symptoms are managed effectively with hospital pain protocols and ease noticeably over the first one to two weeks.
Results depend on the underlying pathology. Complete clipping of a cerebral aneurysm or total removal of a benign tumour like a low-grade meningioma often provides permanent resolution. In malignant brain tumours, surgery successfully removes the initial bulk, but long-term outcomes rely on subsequent oncological therapies and routine monitoring scans.
When performed in licensed tertiary hospitals with experienced neurosurgical teams, intraoperative neuromonitoring, and neuro-intensive care support, craniotomy is a well-established, regulated procedure. As with all major cranial surgery, risks include infection, post-operative haematoma, brain swelling, and temporary neurological deficits, which are minimised through rigorous surgical protocols.
A craniotomy requires removing a bone flap to access lesions on the brain surface or deep within hemispheres. In contrast, endoscopic transnasal surgery enters through the nostrils to reach pituitary and central skull base lesions without external incisions. The appropriate technique depends strictly on the exact anatomical location and lesion size.
Patients should plan a stay of 14 to 21 days in Turkey. This duration covers pre-operative assessments, five to eight days of inpatient hospitalisation, staple removal after 10 to 14 days, and a post-operative scan to confirm complete intracranial air absorption before receiving medical clearance to fly home safely.
Your request is in!
Your coordinator will contact you — usually within 2 hours, 24/7.
Want a faster, more accurate assessment?
Add photos & medical detailsLeave your number — a coordinator calls you in your language, usually within 15 minutes during office hours.
Thank you!
A coordinator will contact you at the time you chose.